About The Study: The results of this study of 61,000 mother-child dyads suggest that postnatal selective serotonin reuptake inhibitor (SSRI) treatment was associated with a reduced risk of postnatal depression–associated maternal mental health problems and child externalizing behaviors across early childhood years. These findings suggest that postnatal SSRI treatment may bring benefits in the long term to women with postnatal depression and their offspring. Authors: Chaoyu Liu, M.D., Ph.D., of King's College in London, is the corresponding author.

https://www.miragenews.com/postnatal-ssri-treatment-impacts-maternal-child-1073990/

#miragenews